Crystal Adam sold TNGX
March 5, 2026 · Form 4 insider transaction
Crystal Adam sold 20,251 shares of Tango Therapeutics, Inc. at $15.00 per share, a transaction worth $303.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
20,251
Price
$15.00
Total value
$303.8K
InsiderCrystal Adam
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 5, 2026
Filing dateMarch 9, 2026
Shares owned after112,622
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.